Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

Reduced dopaminergic function may contribute to cognitive dysfunction in HIV patients with or without additional cocaine abuse. These findings suggest that these HIV patients may benefit from treatments that enhance dopamine function or protection from dopamine cell injury.